Veracyte, Inc. · NASDAQ:VCYT
Febbo Phillip G. sold 13,110 Veracyte, Inc. shares (Form 4)
Traded Sep 2 to Sep 4, 2026 · Filed Sep 4, 2026
From Sep 2 to Sep 4, 2026, Febbo Phillip G. (Chief Scientific & Med Officer) sold 13,110 Veracyte, Inc. shares at an average US$43.05 for US$564K under a trading plan, leaving 133,048 shares. Filed Sep 4, 2026 (Form 4).
- Sold
- 13,110 shares
- Price
- US$43.05 average (US$42.89 to US$43.66)
- Value
- US$564K
- Holding after
- 133,048 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Scientific & Med Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Common Stock | Shares withheld for tax | 3,639 | US$44.88 | 146,158 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 10,405 | US$42.89 | 135,753 | Direct |
| Sep 4, 2026 | Common Stock | Sale | 2,705 | US$43.66 | 133,048 | Direct |